FOERFARANDE FOER FRAMSTAELLNING AV GIFTLOESA CYTOSTATBEREDNINGAR
The invention is related to a process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents administered to them against malign tumors, comprising administering a pharmacologically acceptable salt of a dithiodi-(alkane sulfonic a...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | Finnish |
Published |
18.08.1979
|
Edition | 2 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention is related to a process for the treatment of humans suffering from undesired urotoxic side effects caused by cytostatically active alkylating agents administered to them against malign tumors, comprising administering a pharmacologically acceptable salt of a dithiodi-(alkane sulfonic acid) having the general formula to the human treated with the cytostatically active alkylating agent, in an amount ranging from 20% of the weight of the alkylating agent to the highest tolerated dosage of the salt of the dithiodi-(alkane sulfonic acid), simultaneously or separately in combination with the alkylating agent. |
---|---|
Bibliography: | Application Number: FI19790000426 |